[PDF] Top 20 Sistema de automação residencial para iluminação
Has 10000 "Sistema de automação residencial para iluminação" found on our website. Below are the top 20 most common "Sistema de automação residencial para iluminação".
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
... of patients with nonmyeloid cancer enrolled in commercial or Medicare Advantage plans from March 2015 to June 2016 and receiving filgrastim-sndz or filgrastim-ref during ≥ ... See full document
9
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
... Abstract: Neutropenia and febrile neutropenia (FN) are frequent and potentially fatal toxicities of myelosuppressive anticancer ...the incidence of FN, thus allowing the administration of ... See full document
50
Randomized, Multi Centric, Double Blind Comparative Study To Evaluate Efficacy And Safety Of Biosimilar Pegfilgrastim And Reference Pegfilgastrim In Patients With Chemotherapy Induced Neutropenia (Cin)
... 70 patients were enrolled in study arm and 35 patients in reference ...4 neutropenia in patients receiving study drug / reference drug in the 1 st cycle of chemotherapy ... See full document
65
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
... of chemotherapy, versus a different G-CSF or versus no primary G-CSF ...reported incidence of ...adult cancer patients with solid tumours or lymphoma were ...in patients with leukaemia, ... See full document
26
Granulocyte colony stimulating factors for febrile neutropenia prophylaxis following chemotherapy : systematic review and meta analysis
... of chemotherapy, versus a different G-CSF or versus no primary G-CSF ...reported incidence of ...adult cancer patients with solid tumours or lymphoma were ...in patients with leukaemia, ... See full document
144
INCIDENCES OF CHEMOTHERAPY-INDUCED NEUTROPENIA AND ITS ASSOCIATION WITH TREATMENT OUTCOMES
... general, febrile neutropenia is treated with immediate hospitalization and the administration of intravenous antibiotics [9] ...subsequent chemotherapy dose delays or reductions. A patient with ... See full document
245
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5 fluorouracil
... of febrile neutropenia in patients with esophageal cancer treated using initial DCF ...of febrile neutropenia in multivariate ...suspected among the risk factors for ... See full document
33
Garenoxacin Prophylaxis for Febrile Neutropenia after Chemotherapy in Hematological Malignancies
... Background: Febrile neutropenia is one of the most serious adverse events in pa- tients with hematological malignancies and ...in patients with hematological malignancies is controver- ...for ... See full document
437
Granisetron Transdermal Patch for Treatment of Nausea in Patients Undergoing Cisplatin Based Chemotherapy for Cervical Cancer
... records. Patients were included if they re- ceived at least a partial dose of cisXRT and Sancuso ® patch as standard antiemetic prophylaxis prior to cisXRT for cer- vical cancer ...and/or ... See full document
140
Bacterial infection profiles in lung cancer patients with febrile neutropenia
... of febrile neutropenia does not differ greatly from that seen in other types of ...the patients’ fragility than the nature of the germs or the presence of multidrug ... See full document
9
The practical approach of febrile neutropenia in cancer patients in the emergency room
... of chemotherapy in smaller time ...of neutropenia is greater than 20% with the use of chemotherapy, it is recommended the use of prophylactic granulocyte colony-stimulating factor 28 ... See full document
16
Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony stimulating factor (filgrastim) – a prospective, placebo controlled, double blind study
... Blood samples were drawn at study entry (baseline), day 4 and day 7 afterwards. The samples were taken be- fore administration of the study drug. The sampling was performed only during the ICU stay and if a ... See full document
17
ANXIOLYTIC AND ANTIEMETIC EFFECTS OF AROMATHERAPY IN CANCER PATIENTS ON ANTICANCER CHEMOTHERAPY
... in cancer patients 16 . In addition to reducing anxiety in cancer patients, there is also evidence that treatment with aromatherapy massage may affect the immune system 10 ...in ... See full document
22
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model
... Because of the high potency of G-CSF with respect to the stimulation of granulopoiesis with different modes of action and the strong relationship between neutrophil counts and drug clearance, the application of G-CSF ... See full document
71
Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital
... hood cancer patients to provide coverage for virulent organisms while minimizing exposure to unnecessary antibiotics, because indiscriminant use of broad-spec- trum antibiotics may accelerate antibiotic ... See full document
7
INTERNATIONAL COLUMN Effectiveness of acupressure on the experience of nausea and vomiting among patients receiving chemotherapy
... experienced chemotherapy-induced nausea and vomiting although they were receiving antiemet- ...of patients who receive cancer chemotherapy experience some degree of nausea and ...of ... See full document
10
THE RISK FACTOR OF NEUTROPENIA ON LOCALLY ADVANCED BREAST CANCER PATIENTS TREATED WITH FIRST CYCLE CYCLOPHOSPHAMIDE, DOXORUBICINE, 5- FLUOROURACIL CHEMOTHERAPY AT SANGLAH GENERAL HOSPITAL DENPASAR, BALI-INDONESIA
... of neutropenia. In this study, 27.4% of breast cancer patients experienced neutropenia after first series CAF ...aggressive chemotherapy with high doses hence side effects are more ... See full document
10
Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy
... ethics committee of the internal review board of the Semnan University of Medical Sciences. Demographics data, disease characteristics, and co-morbidities (including current smoking and diabetes) were collected by face ... See full document
22
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
... in chemotherapy-induced neutropenia: a multicenter dose-find- ing study in women with breast ...daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or ... See full document
8
Granulocyte Colony-Stimulating Factor Use in a Large Iranian Hospital: Comparison with American Society of Clinical Oncology (ASCO) Clinical Practice Guideline
... our patients (N=34) had a hematological malignancy which usually takes longer time to recover compared with solid ...(7%) patients took longer than 7 days for ANC to recover and hence had longer hospital ... See full document
13
Related subjects